T1	Participants 40 74	children and young adults with HIV
T2	Participants 172 262	HIV-infected patients and associated with increased risk of disease severity and morbidity
T3	Participants 452 473	HIV-infected subjects
T4	Participants 516 636	perinatally acquired HIV (PHIV)-infected subjects or behaviorally acquired HIV (BHIV)-infected subjects (5.0-24.9 years)
T5	Participants 746 863	Fifty-eight subjects enrolled (67% male, 85% African American and 64% BHIV) and 50 completed with no safety concerns.
